Stefani Spranger
Ragon Institute of MGH, MIT and Harvard · 279 works · 19,500 citations · h-index 50
Top works
- Up-Regulation of PD-L1, IDO, and T regs in the Melanoma Tumor Microenvironment Is Driven by CD8 + T Cells
- Melanoma-intrinsic β-catenin signalling prevents anti-tumour immunity
- STING-Dependent Cytosolic DNA Sensing Mediates Innate Immune Recognition of Immunogenic Tumors
- Loss of PTEN Promotes Resistance to T Cell–Mediated Immunotherapy
- Tumor-Residing Batf3 Dendritic Cells Are Required for Effector T Cell Trafficking and Adoptive T Cell Therapy
- Mechanism of tumor rejection with doublets of CTLA-4, PD-1/PD-L1, or IDO blockade involves restored IL-2 production and proliferation of CD8+ T cells directly within the tumor microenvironment
- Cancer immunotherapy strategies based on overcoming barriers within the tumor microenvironment
- WNT/β-catenin Pathway Activation Correlates with Immune Exclusion across Human Cancers
- Molecular Drivers of the Non–T-cell-Inflamed Tumor Microenvironment in Urothelial Bladder Cancer
- Impact of oncogenic pathways on evasion of antitumour immune responses
- Density of immunogenic antigens does not explain the presence or absence of the T-cell–inflamed tumor microenvironment in melanoma
- Molecular Pathways: Targeting IDO1 and Other Tryptophan Dioxygenases for Cancer Immunotherapy
- Innate immune signaling and regulation in cancer immunotherapy
- Pharmacologic Inhibition of MALT1 Protease by Phenothiazines as a Therapeutic Approach for the Treatment of Aggressive ABC-DLBCL
- Increased demand for NAD+ relative to ATP drives aerobic glycolysis
- Mechanisms of tumor escape in the context of the T-cell-inflamed and the non-T-cell-inflamed tumor microenvironment
- Cancer Immunotherapy Targets Based on Understanding the T Cell-Inflamed Versus Non-T Cell-Inflamed Tumor Microenvironment
- Intratumoral CD8+ T-cell Apoptosis Is a Major Component of T-cell Dysfunction and Impedes Antitumor Immunity
- Type I interferon activates MHC class I-dressed CD11b+ conventional dendritic cells to promote protective anti-tumor CD8+ T cell immunity
- WNT Signaling in Cancer Immunosurveillance